Advisory Board

Mansfield Bio-Incubator's Advisory Board members represent a group of healthcare and life-sciences professionals from diverse specialties who both advise the Leadership Team and are available as resources to Incubator companies.

Eugene Buff, MD, PHD

Dr. Eugene Buff is a Registered Technology Transfer Professional (RTTP) and Certified Licensing Professional (CLP) with over twenty years of combined scientific, consulting and management experience. He has substantial expertise in a wide variety of industries, including but not limited to healthcare, biotechnology, medical devices, consumer products, materials and chemical manufacturing.

Dr. Buff is a Founder and President of Primary Care Innovation Consulting (PCIC), a new type of innovation management and business development firm supporting companies’ growth through open innovation. PCIC provides technology strategy consulting for both large and small companies globally and has unique access to cutting edge innovation at universities, incubators and accelerators worldwide. Its signature product, Innovation Navigator™ offers comprehensive business development support by combining known theories (such as Lean Start Up, “Jobs-To-Be-Done” and Disruptive Innovation) with years of successful consulting practices. Dr. Buff also designs and delivers variety of training and educational programs on innovation, entrepreneurship, technology scouting and technology commercialization.

Dr. Buff earned his Master degree in Biochemistry as well as his Medical Doctor degree from Russian State Medical University. He is also a Ph.D. in Genetics and is a coauthor of 14 papers in peer reviewed international journals. Eugene is an active member of the Licensing and Technology Transfer community and serves on several committees and task forces at AUTM and LES. He is a member on many consulting and professional network organizations and often mentors and presents on issues of Entrepreneurship, Intellectual Property, Innovation and Technology Transfer both in US and internationally.


Shelley is a Founder and Principal of ShelleyCO, LLC.  Her primary mission is to help busy entrepreneurs meet the right people for valuable business development alliances. Over the last 20 years, she developed a broad and deep network comprising virtual and early stage life science and healthcare companies, women’s health organizations, angel and venture capital investors, contract research organizations, non-profits, and government. She is the co-founder of CreaGen Chemistry Incubator C2I and was instrumental in helping the NSIV Incubator launch.  She is currently a consultant and board advisor for another regional incubator, SKY-VENTURES (Natick).  Shelley's network, know-how about industry trends and needs, and leadership skills have been an asset to the growth of these incubators and to bringing greater and more positive attention to the growth of this sector.

Michael Sherman, PHD

Dr. Sherman is a professor and Program Leader of the Hormone Responsive Cancer Project at Boston University Cancer Center.  Prior to that, he held various positions at Boston Biomedical Research Institute and Harvard University.  He also serves as a Scientific Advisor to CureLab, Inc., a biotechnology company committed to the development of effective vaccines against infectious disease and cancer, and is a co-founder at Quateris Inc., a startup company that is developing a tool for multiplex nucleic acid-protein interactions.  Dr. Sherman is a member of numerous study sections for the grant review and the editorial board of multiple scientific journals.  He is a well-recognized leader in the field of heat-shock proteins' role in cancer and co-author of over 90 peer-reviewed publications, 5 patents and 6 book chapters.


Dr. Bolduc is Director of Massasioit Community College's Biotechnology Certificate Program and Associate Professor in Biology at Massasoit.  As Director, he designed the program and a new state-of-the-art biotechnology laboratory space.  He was awarded grants that supplied the lab with the latest equipment and which support an undergraduate research program.  Prior to coming to Massasoit, Dr. Bolduc was CMC Team Leader at Cequent Pharmaceuticals, Inc and is co-inventor of a U.S. and international patent based on Cequent's lead biologic.